The CMCR seeks to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts.
Current studies examine the effects of cannabis and cannabinoids on a range of psychiatric, developmental and pain conditions, as well as the impact of use on public safety (e.g., driving). A list of current and past studies can be found here.
Planning is currently underway for the CMCR Symposium for Spring 2022. Please check back for updates. Information on the CMCR symposium series, including archives of previous meetings, can be found here.